Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Challenges faced by patients with morphea in the era of SARS-CoV-2
By
- AMS
posted
Jun 09, 2020 03:24 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy
- AMS
Added Dec 23, 2020
Blog Entry
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris
- AMS
Added Jan 12, 2021
Blog Entry
Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic
- AMS
Added Oct 01, 2020
Blog Entry
‘Aesthetic One®’ App Developed by The Aesthetic Society Registers Over 6,000 Breast Implants
- AMS
Added Nov 24, 2021
Blog Entry
Women in Aesthetics: Sheila Barbarino, MD: Rising to the Challenge
Informa Admin
Added Dec 06, 2022
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic